GFAP and neoplasm: The major finding of this study is that the pretreatment serum lactate level is a more valuable prognostic biomarker than other biomarkers, including neuronal (NSE, S100β, and GFAP) and nonneuronal (NGAL and LDH) biomarkers, in patients with supratentorial primary brain tumors undergoing tumor resection.